Article Details

FDA approves AstraZeneca, Daiichi drug in breast cancer first | BioPharma Dive

Retrieved on: 2022-08-05 19:16:30

Tags for this article:

Click the tags to see associated articles and topics

FDA approves AstraZeneca, Daiichi drug in breast cancer first | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/enhertu-her2-low-breast-cancer-fda-approval-astrazeneca/629003/

Excerpt

On Friday, the Food and Drug Administration approved Enhertu, a medicine developed by AstraZeneca and Japanese drugmaker Daiichi Sankyo, for patients ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up